Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?

. 2022 May ; 166 (2) : 228-235. [epub] 20210702

Jazyk angličtina Země Česko Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid34282806

BACKGROUND: Acromegaly is a disorder associated with hypersecretion of growth hormone, most usually caused by a pituitary adenoma. Dysmotility of the gastrointestinal tract has been reported in acromegalic patients. Achalasia is a disorder characterized by aperistalsis of the oesophagus with incomplete lower oesophageal sphincter relaxation and whose aetiology remains unknown. Mutations in some genes have previously been associated with the development of acromegaly or achalasia. The study aims were to analyse mutations in selected genes in a woman having both of these diseases, to identify their aetiological factors, and to suggest explanations for the co-incidence of acromegaly and achalasia. METHODS AND RESULTS: A female patient with acromegaly, achalasia, and a multinodular thyroid gland with hyperplastic colloid nodules underwent successful treatment of achalasia via laparoscopic Heller myotomy, a thyroidectomy was performed, and the pituitary macroadenoma was surgically excised via transnasal endoscopic extirpation. Germline DNA from the leukocytes was analysed by sequencing methods for a panel of genes. No pathogenic mutation in AAAS, AIP, MEN1, CDKN1B, PRKAR1A, SDHB, GPR101, and GNAS genes was found in germline DNA. The somatic mutation c.601C>T/p.R201C in the GNAS gene was identified in DNA extracted from a tissue sample of the pituitary macroadenoma. CONCLUSIONS: We here describe the first case report to our knowledge of a patient with both acromegaly and achalasia. Association of acromegaly and soft muscle tissue hypertrophy may contribute to achalasia's development. If one of these diagnoses is determined, the other also should be considered along with increased risk of oesophageal and colorectal malignancy.

Zobrazit více v PubMed

Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25(1):102-52. DOI

Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest 2009;119(11):3189-202. PubMed DOI

Lugo G, Pena L, Cordido F. Clinical Manifestations and Diagnosis of Acromegaly. Int J Endocrinol 2012;2012:540398. PubMed DOI

Ilhan M, Danalioglu A, Turgut S, Karaman O, Arabaci E, Tasan E. Acromegaly can be associated with impairment of LES relaxation in the oesophagus. Endokrynol Pol 2015;66(4):308-12. PubMed DOI

George B, Vinay D, Moolechery J, Mathew V, Anantharaman R, Ayyar V, Bantwal G. Megaduodenum in a patient with acromegaly. Indian J Endocrinol Metab 2012;16(Suppl 2):S324-5. PubMed DOI

Kršek M. Acromegaly: current view. Vnitr Lek 2015;61(10):900-4. (In Czech) PubMed

Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 2004;89(2):667-74. PubMed DOI

Gadelha MR, Kasuki L, Korbonits M. The genetic background of acromegaly. Pituitary 2017;20(1):10-21. PubMed DOI

Furuzawa-Carballeda J, Torres-Landa S, Valdovinos MÁ, Coss-Adame E, Martín Del Campo LA, Torres-Villalobos G. New insights into the pathophysiology of achalasia and implications for future treatment. World J Gastroenterol 2016;22(35):7892-907. PubMed DOI

Amr BS, Mamillapalli C. Achalasia in a Patient with Polyglandular Autoimmune Syndrome Type II. Case Rep Gastroenterol 2015;9(2):160-64. PubMed DOI

Ates F, Vaezi MF. The Pathogenesis and Management of Achalasia: Current Status and Future Directions. Gut Liver 2015;9(4):449-63. PubMed DOI

Birgisson S, Richter JE. Achalasia in Iceland, 1952-2002: An Epidemiologic Study. Dig Dis Sci 2007;52(8):1855-860. DOI

Farrukh A, DeCaestecker J, Mayberry JF. An epidemiological study of achalasia among the South Asian Population of Leicester, 1986-2005. Dysphagia 2008;23(2):161-64. PubMed DOI

Gennaro N, Portale G, Gallo C, Rocchietto S, Caruso V, Costantini M, Salvador R, Ruol A, Zaninotto G. Esophageal achalasia in the Veneto region: epidemiology and treatment. Epidemiology and treatment of achalasia. J Gastrointest Surg 2011;15(3):423-8. PubMed DOI

Sadowski DC, Ackah F, Jiang B, Svenson LW. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010;22(9):e256-61. DOI

Kim E, Lee H, Jung HK, Lee KJ. Achalasia in Korea: an epidemiologic study using a national healthcare database. J Korean Med Sci 2014;29(4):576-80. DOI

Tebaibia A, Boudjella MA, Boutarene D, Benmediouni F, Brahimi H, Oumnia N. Incidence, clinical features and para-clinical findings of achalasia in Algeria: Experience of 25 years. World J Gastroenterol 2016;22(38):8615-623. PubMed DOI

Esposito D, Maione F, D'Alessandro A, Sarnelli G, De Palma GD. Endoscopic treatment of esophageal achalasia. World J Gastrointest Endosc 2016;8(2):30-9. PubMed DOI

Alhussaini B, Gottrand F, Goutet JM, Scaillon M, Michaud L, Spyckerelle C, Viola S, Lamblin MD. Clinical and manometric characteristics of Allgrove syndrome. J Pediatr Gastroenterol Nutr 2011;53(3):271-4. PubMed DOI

Krumbholz M, Koehler K, Huebner A. Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome - Shedding light on an unexpected splice mutation. Biochem Cell Biol 2006;84(2):243-49. DOI

Hall, TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleids Acids Symposium Ser 1999;41:95-98.

Torresan F, Ioannou A, Azzaroli F, Bazzoli F. Treatment of achalasia in the era of high-resolution manometry. Ann Gastroenterol 2015;28(3):301-08. PubMed

Moonen A, Boeckxstaens G. Current Diagnosis and Management of Achalasia. J Clin Gastroenterol 2014;48(6):484-90. PubMed DOI

Familiari P, Greco S, Volkanovska A, Gigante G, Cali A, Boškoski I, Costamagna G. Achalasia: current treatment options. Expert Rev Gastroenterol Hepatol 2015;9(8):1101-14. DOI

Hana V, Svancara J, Bandurova L, Brabec P, Cap J, Durovcová V, Dvorakova E, Hana V Jr., Jarkovcova Z, Kentos P, Klimes D, Krcma M, Krsek M, Lazurova I, Olsovska V, Podoba J, Pura M, Sasikova M, Stary K, Strenkova J, Siprova H, Steno J, Trejbalova L, Vanuga P, Wagnerova H, Weiss V, Zeman D, Dusek L, Marek J. Register of Sellar Tumors - RESET: Diagnostics and Therapy of Acromegaly in Czech and Slovak Republics in the 21th Century. Diabetologie, Metabolismus, Endokrinologie a Výživa 2013;16(4):219-24. (In Czech) DOI

Bałdys-Waligórska A, Krzentowska A, Gołkowski F, Sokołowski G, Hubalewska-Dydejczyk A. The prevalence of benign and malignant neoplasms in acromegalic patients. Endokrynol Pol 2010;61(1):29-34. PubMed

Rokkas T, Pistiolas D, Sechopoulos P, Margantinis G, Koukoulis G. Risk of colorectal neoplasm in patients with acromegaly: a meta-analysis. World J Gastroenterol 2008;14(22):3484-9. DOI

Nair AS, Nirale AM, Sriprakash K, Gopal TV. Dilated cardiomyopathy in acromegaly: Case report and anesthesia management. Anesth Essays Res 2013;7(3):411-4. DOI

Marchese M, Spada C, Tringali A, Iacopini F, Farniliari P, Belmonte M, Petruzziello L, Mntignani M, Costamagna G. Esophageal motility in 23 acromegalic patients. Digest Liver Dis 2006; 38: Supplement 1:S133. DOI

Porschen R, Molsberger G, Kühn A, Sarbia M, Borchard F. Achalasia-associated squamous cell carcinoma of the esophagus: flow-cytometric and histological evaluation. Gastroenterology 1995;108(2):545-9. DOI

Streitz JM Jr, Ellis FH Jr, Gibb SP, Heatley GM. Achalasia and squamous cell carcinoma of the esophagus: analysis of 241 patients. Ann Thorac Surg 1995;59(6):1604-9. DOI

Kroupa R, Starý K, Hep A, Suchánková J, Dolina J. Higher incidence of thyropathy in patients with oesophageal achalasia. Genetic, autoimmune, regional or just a random association?. Vnitr Lek 2008;54(4):341-5. (In Czech) PubMed

Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009;161(1):11-20. PubMed DOI

Bartges JW, Nielson DL. Reversible megaesophagus associated with atypical primary hypoadrenocorticism in a dog. J Am Vet Med Assoc 1992;201(6):889-91. PubMed

Bowen D, Schaer M, Riley W. Autoimmune polyglandular syndrome in a dog: a case report. J Am Anim Hosp Assoc 1986;22:649-53.

Fritzen R, Bornstein SR, Scherbaum WA. Megaoesophagus in a patient with autoimmune polyglandular syndrome Type II. Clin Endocrinol 1996;45(4):493-98. DOI

Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001;10(3):283-90. PubMed DOI

Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989;340(6236):692-96. PubMed DOI

Salenave S, Boyce AM, Collins MT, Chanson P. Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 2014;99(6):1955-69. PubMed DOI

Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis 2008;3:12. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...